The natural evolution of haemophilia care: Developing and sustaining comprehensive care globally

Haemophilia

Volumn 12, Issue SUPPL. 3, 2006, Pages 13-21

  Evatt, Bruce L ^a  

^a WORLD FEDERATION OF HEMOPHILIA   (Canada)

Author keywords

Cost of care; Haemophilia; Haemophilia care advocacy; Haemophilia treatments centres; Health resource utilization; Physician shortage

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR CONCENTRATE;

ARTICLE; COOPERATION; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; CRYOPRECIPITATE; DEVELOPED COUNTRY; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE NEED; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH CENTER; HEMOPHILIA; HUMAN; NON PROFIT ORGANIZATION; NONBIOLOGICAL MODEL; PATIENT ADVOCACY; PERSONNEL SHORTAGE; PHYSICIAN ATTITUDE; PREVENTIVE MEDICINE; PRIORITY JOURNAL;

COMPREHENSIVE HEALTH CARE; HEALTH CARE COSTS; HEALTH SERVICES; HEMOPHILIA A; HUMANS; MALE; PATIENT ADVOCACY; PHYSICIANS;

EID: 33646154242     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01256.x     Document Type: Article

References (46)

1. Pool J, Hershgold E, Pappenhagen A. High-potency antihemophilic factor concentrates from cryoglobulin precipitate. Nature 1964; 203: 312.
2. Levine PH, McVerry BA, Segelman AE, Cranford CM, Zimbler S. Comprehensive health care clinic for hemophiliacs. Arch Intern Med 1976; 136: 792-4.
3. Smith PS, Keyes NC, Forman EN. Socioeconomic evaluation of a state-funded comprehensive hemophilia-care program. N Engl J Med 1982; 306: 575-9.
4. Smith PS, Levine PH. The benefits of comprehensive care of hemophilia: A five-year study of outcomes. Am J Public Health 1984; 74: 616-7.
5. Jones P. Hemophilia home therapy. Homeostasis 1992; 22: 247-50.
6. Ludlam CA. Comprehensive care and delivery of care: The developed world. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Haemophilia Malden. MA, USA: Blackwell, 2005: 350-65.
7. Association of Hemophilia Clinic Directors of Canada. Hemophilia and von Willebrand's disease: 1. Diagnosis, comprehensive care and assessment. Can Med Assoc J 1995; 153: 19-25.
8. Manco-Johnson MJ, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb Hemost 2003; 29: 585-94.
9. Soucie JM, Cianfrini C, Janco RL et al. Joint range of motion limitations among young males with hemophilia: Prevalence and risk factors. Blood 2004; 103: 2467-73 [Epub 13 November, 2003].
10. Steen Carlsson K, Hojgard S, Glomstein A et al. On demand vs. prophylactic treatment for severe hemophilia in Norway and Sweden: differences in treatment characteristics and outcome. Hemophilia 2003; 9: 555-66.
11. Kasper CK, Mannucci PM, Boulyzenkov V et al. Haemophilia in the 1990s: principles of treatment and improved access to care. Semin Thromb Hemost 1992; 18: 1-10.
12. Berntorp E, Boulyzenkov V, Brettler D et al. Modern treatment of haemophilia. Bull World Health Organ 1995; 73: 691-701.
13. Srivastava A, Viswabandya A. Comprehensive care and delivery of care: the developing world. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Haemophilia Malden. MA, USA: Blackwell, 2005: 366-70.
14. Hoots WK. Comprehensive care for hemophilia and related inherited bleeding disorders: Why it matters. Curr Hematol Rep 2003; 2: 395-401.
15. Report of a Joint WHO/WFH meeting. Control of Haemophilia: Haemophilia Care in the Developing World. Geneva, 16-17 June, 1997 (WHO/GHN/WFH/WG/ 98.3).
16. Globe DR, Cunningham WE, Andersen R et al. The Hemophilia Utilization Group Study (HUGS): Determinants of costs of care in persons with haemophilia A. Hemophilia 2003; 9: 325-31.
17. Schramm W, Royal S, Kroner B et al. Clinical outcomes and resource utilization associated with haemophilia care in Europe. Hemophilia 2002; 8: 33-43.
18. Santiago-Borrero PJ, Ortiz I, Rivera-Caragol E, Maldonado NI. Financial aspects of hemophilia care in Puerto Rico and other Latin American countries. Hemophilia 1999 Nov; 5: 386-91.
19. Martinez-Murillo C, Quintana S, Ambriz R et al. An economic model of haemophilia in Mexico. Haemophilia 2004; 10: 9-17.
20. Miners AH. The economics of hemophilia treatments. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Haemophilia Malden. MA, USA: Blackwell, 2005: 351-58.
21. Smith PS, Teutsch SM, Shaffer PA, Rolka H, Evatt B. Episodic versus prophylactic infusions for hemophilia A: A cost-effectiveness analysis. J Pediatr 1996;129: 424-31.
22. Globe D, Cunningham W, Andersen R et al. The Hemophilia Utilization Study Group. Cost of outpatient, inpatient and pharmaceutical care. Int J Pediatr Hematol Oncol 2001; 7: 87-100.
23. Globe DR, Curtis RG, Keorper MA et al. Utilization of care in haemophilia: A resource-based method for cost analysis from the Haemophilia Utilization Group Study (HUGS). Haemophilia 2004; 10 (Suppl. 1): 63-70.
24. Tezanos Pinto M, Ortiz Z. Haemophilia in the developing world: successes, frustrations and opportunities. Haemophilia 2004; 10 (Suppl. 4): 14-9.
25. O'Mahony B. WFH: Back to the future. Haemophilia 2004; 10 (Suppl. 4): 1-8.
26. Chandy M, O'Mahoney B, Giangrande P et al. Submission to the WHO Expert Committee on the Selection and Use of Essential Medicines. Montreal: WFH, 2004.
27. Evatt BL, Robillard L. Establishing hemophilia care in developing countries: Using data to overcome the barrier of pessimism. Hemophilia 2000; 6: 131-4.
28. Evatt BL, Black C. Comprehensive care and delivery of care: The global perspective. In: Lee CA, Berntorp EE, Hoots WK, eds. Textbook of Haemophilia Malden. MA, USA: Blackwell, 2005: 371-77.
29. Soucie JM, Symons J 4th, Evatt B, Brettler D, Huszti H, Linden J. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia. Haemophilia 2001; 7: 198-206.
30. Soucie JM, Nuss R, Evatt B et al. Mortality among males with hemophilia: relations with source of medical care. Blood 2000; 96: 437-42.
31. Isarangkura P, Chuansumrit A. Developing and maintaining the hemophilia program in Thailand. Southeast Asian J Trop Med Public Health 1993; 24 (Suppl. 1): 61-5.
32. Evatt BL, Black C, Batorova A, Street A, Srivastava A. Comprehensive care for haemophilia around the world. Haemophilia 2004; 10 (Suppl. 4): 9-13.
33. Ricard KA. The impact of HIV on health care delivery in haemophilia. Prog Clin Bio Res 1990; 324: 101-11.
34. Farrugia A, Manno CS, Evatt BL. Emerging and receding risks of therapeutic regimens for hemophilia. Haemophilia 2004; 10 (Suppl. 4): 47-54.
35. National Hemophilia Foundation Survey of United States Hemophilia Treatment Centers. New York: National Hemophilia Foundation, 2000.
36. AMA Workforce Information and Summary Statistics 1995-2004. Washington, DC: American Medical Association.
37. Brown LK, Schultz JR, Forsberg AD, King G, Kocik SM, Butler RB. Predictors of retention among HIV/hemophilia health care professionals. Gen Hosp Psychiatry 2002; 24: 48-54.
38. National Conference of State Legislators. Strategy 8: Managing Health Care Better. Washington, DC, 2005.
39. CDC Minutes of Workshop to Discuss Better Utilization of HTCs to Meet Increased Demands on Services. Atlanta, GA: Centers for Disease Control, 1999.
40. Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: A survey of 75 women enrolled in haemophilia treatment centres in the Unites States. Haemophilia 2004; 10: 158-61.
41. Resnik S. Blood Saga. Berkley, CA: University of California Press, 1999.
42. Leveton LB, Sox HC, Stoto MA. HIV and the Blood Supply: An Analysis of Crisis Decision-making. Washington, DC: Institute of Medicine, National Academy Press, 1995.
43. O'Mahony B. Hemophilia Societies: Challenges and Development. WFH Hemophilia Organization Development Monograph no. 1. Montreal: WFH, 2000.
44. Clarke G. Action Planning. WFH Hemophilia Organization Development Monograph no. 2. Montreal: WFH, 2001.
45. Page D. Making Your Case Effectively: A Guide to Government Relations. WFH Hemophilia Organization Development Monograph no. 5. Montreal: WFH, 2004.
46. Hashim A. Recruiting and Retaining Volunteers. WFH Hemophilia Organization Development Monograph no. 3. Montreal: WFH, 2003.